First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial

Journal for ImmunoTherapy of Cancer(2014)

引用 2|浏览11
暂无评分
关键词
Adoptive Transfer,Chimeric Antigen Receptor,Ongoing Phase,Post Infusion,Significant Grade
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要